SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of December 23, 2020, between Guided Therapeutics, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Security Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Nevada
This COMMON STOCK PURCHASE WARRANT (the "Warrant") certifies that, for value received (in connection with the issuance of the convertible promissory note in the principal amount of $112,750.00 to the Holder (as defined below) of even date) (the "Note"), Auctus Fund, LLC, a Delaware limited liability company (including any permitted and registered assigns, the "Holder"), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date of issuance hereof, to purchase from Guided Therapeutics, Inc., a Delaware corporation (the "Company"), up to 250,000 shares of Common Stock (as defined below) (the "Warrant Shares") (whereby such number may be adjusted from time to time pursuant to the terms and conditions of this Warrant) at the Exercise Price per share then in effect. This Warrant is issued by the Company as of the date hereof in connection with that certain securities purchase agreement dated March 31, 202
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Common Stock Purchase Warrant • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, __________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on _________, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Guided Therapeutics, Inc., a Delaware corporation (the “Company”), up to _________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Common Stock Purchase Warrant • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) is pursuant to the Company’s Board approval, dated March 2, 2021, for advisory services provided in connection with certain Canadian investors that participated in the Company’s Series F financing. This Warrant is executed by Guided Therapeutics and Aspen Capital Corporation on March 3, 2021 and certifies that, for value received, Aspen Capital Corporation or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on March 3, 2024 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Guided Therapeutics, Inc., a Delaware corporation (the “Company”), up to 196,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant
COMMON STOCK PURCHASE WARRANT GUIDED THERAPEUTICS, INC.Common Stock Purchase Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) is pursuant to the Finder’s Fee Agreement executed by Guided Therapeutics and IRON STONE CAPITAL on January 6, 2020 and certifies that, for value received, IRON STONE CAPITAL or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on April 23, 2023 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Guided Therapeutics, Inc., a Delaware corporation (the “Company”), up to 59,600 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES G PREFERRED STOCK PURCHASE AGREEMENTSeries G Preferred Stock Purchase Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
This SERIES G PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement"), dated as of February 2, 2021, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation, with its address at 5835 Peachtree Corners East, Suite B, Norcross, Georgia 30092 (the "Company"), and POWER UP LENDING GROUP, LTD., a New York corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the "Buyer").
Re: Finder's Fee Agreement Dear Gene Cartwright:Finder's Fee Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • New York
As you know, Guided Therapeutics, Inc. (the ' Issuer"), has expressed an interest in obtaining private equity or debt capital for various purposes. This letter agreement ("Agreement") sets forth the terms and conditions upon which
THIS AGREEMENT is dated March.10, 2021 (the "Effective Datel') BETWEEN:Finder's Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus • Washington
Guided Therapeutics. Inc. ("GTI" or lithe Company"), a US registered public company incorporated in the State of Delaware with a registered and records office at 5835 Peachtree Corners East,·Suite B, Peachtree Corners, GA 30092.
EXCHANGE AGREEMENTExchange Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
This EXCHANGE AGREEMENT (this “Agreement”) is made and entered into effective as of May 22, 2020, by and between GUIDED THERAPEUTICS, INC., a Delaware corporation (the “Company”) and Auctus Fund, LLC, a Delaware limited liability company (the “Creditor”).
AMENDED FINDER'S FEE AGREEMENTFinder's Fee Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
Guided Therapeutics Inc., a US registered public company incorporated in the State of Delaware with a registered and records office at 5835 Peachtree Corners East, Suite B Norcross GA 30092.
EXCHANGE AGREEMENTExchange Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
This EXCHANGE AGREEMENT (this "Agreement") is made and entered into effective as of the ____day of March, 2021 by and between GUIDED THERAPEUTICS, INC.,
AMENDMENT # 1 TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE PROMISSORY NOTE DATED DECEMBER 17, 2019Securities Purchase Agreement and Senior Secured Convertible Promissory Note • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
THIS AMENDMENT #1 (the “Amendment”) TO THE SECURITIES PURCHASE AGREEMENT AND SENIOR SECURED CONVERTIBLE PROMISSORY NOTE dated December 17, 2019, is made effective as of May 27, 2020 (the “Effective Date”), by and between Guided Therapeutics, Inc. a Delaware corporation (the “Company”), and Auctus Fund, LLC, a Delaware limited liability company (the “Holder”) (collectively the “Partiers”).
EXCHANGE AGREEMENTExchange Agreement • April 7th, 2021 • Guided Therapeutics Inc • Electromedical & electrotherapeutic apparatus
This EXCHANGE AGREEMENT (this "Agreement") is made and entered into effective as of the 9th day of July, 2020 by and between GUIDED THERAPEUTICS, INC., a Delaware corporation (the "Company") and the undersigned creditor of the Company (the "Creditor").
